NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . September 14th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Flu Vaccines - NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate

Addiction Medicine - Scientists at University of British Columbia publish research in addiction medicine

Angiogenesis - Researchers from University of Ulster report on findings in angiogenesis

Breast Cancer - Research from Washington University, Medical Department provides new data about breast cancer

Breast Cancer - Research reports on breast cancer from F. Nole and colleagues provide new insights

Breast Cancer - Research results from H. Mouridsen and colleagues update understanding of breast cancer

Breast Cancer - Researchers from University of Witwatersrand report details of new studies and findings in the area of breast cancer

Cancer - Study data from J. Lee and co-authors update knowledge of cancer

Drug Resistance - New data from R.P. Tang et al illuminate research in drug resistance

Enzyme Research - Researchers from New York University report on findings in enzyme research

Gastrointestinal Stromal Tumors - Study results from S. George and colleagues in the area of gastrointestinal stromal tumors published

Glioblastoma - Research on glioblastoma described by A.A. Brandes and colleagues

Heart Failure - Research from Indiana University, Medical Department in the area of heart failure described

HIV/AIDS - New HIV/AIDS study results from C.J. Montoya et al described

Liver Cancer - New findings from R.K. Ramanathan and co-researchers in the area of liver cancer described

Myelodysplastic Syndrome - Data on myelodysplastic syndrome reported by researchers at University of Texas

Myeloma - Reports from A. Conroy and colleagues advance knowledge in myeloma

Non-Small Cell Lung Cancer - Data from K. Tsujino and colleagues advance knowledge in non-small cell lung cancer

Non-Small Cell Lung Cancer - Research on non-small cell lung cancer discussed by T.J. Lynch and co-researchers

Non-Small Cell Lung Cancer - Researchers from University of Minnesota describe findings in non-small cell lung cancer

Pancreatic Cancer - Data on pancreatic cancer discussed by researchers at Gyeongsang National University, Medical Department

Prostate Cancer - Studies conducted at M.J. Morris et al on prostate cancer recently published

Type 2 Diabetes - Findings from A.M. Brooks and co-researchers advance knowledge in type 2 diabetes

Esophageal Cancer Therapy - Research from Shanghai Jiao Tong University, Department of Oncology has provided new information about esophageal cancer therapy

Non-Small Cell Lung Cancer Therapy - New findings from Yokohama Municipal Citizen's Hospital describe advances in non-small cell lung cancer therapy

Basal Cell Cancer - Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine

Bioengineering - SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company

Bioscience - Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain

Cancer - Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs

Celladon Corporation - Celladon Corporation and Momentum Research Complete Enrollment of MYDICAR(R) Phase 2 Study of First-in-Human Gene Transfer to Treat Patients with Advanced Heart Failure

Clinical Trial Research - Cytopia's CYT387 Receives FDA Clearance to Start US Clinical Trials

CytRx Corporation - CytRx Reports Favorable Progress Update for Its Pivotal Phase 2 Clinical Trial with Tamibarotene as a Third-line Treatment for Acute Promyelocytic Leukemia

DSG Inc. - DSG Tops Clinical Trial Market on the Inc. 500

Genzyme Corporation - FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in Adult AML

Genzyme Corporation - FDA Advisory Committee to Discuss Genzyme's Clolar for Adult AML on September 1

Glioblastoma - Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrine's Cotara(R) for Treatment of Brain Cancer

Knopp Neurosciences Inc. - Knopp Neurosciences Receives FDA Fast Track Designation for KNS-760704 in ALS

Peplin, Inc. - LEO Pharma to Acquire Peplin for US$287.5m

Peplin, Inc. - Peplin Results for the Financial Year Ended 30 June 2009

Stanford University Medical Center - Stanford Recruiting Participants for H1N1 Flu Vaccine Trial

TCA Cellular Therapy - TCA Cellular Therapy Presents Adult Stem Cell Findings to European Society of Cardiology Congress

TransPharma Medical Ltd. - TransPharma Announces Successful Completion of Phase 2 Trial of ViaDerm-hPTH 1-34 in Postmenopausal Women with Osteoporosis

University of California - Los Angeles - Avastin dramatically improves response, survival in deadly recurrrent glioblastomas

Women's Health - Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial

Xencor, Inc. - Xencor Appoints Jeffrey V. Ravetch of the Rockefeller University to its Scientific Advisory Board

XenoPort, Inc. - XenoPort Reports Positive Results from a Phase 2 Trial of Arbaclofen Placarbil in Spinal Cord Injury Patients with Spasticity



Return to Top of Page

-----------------------
PR Login